Accurate representation of the hepatitis C virus quasispecies in 5.2-kilobase amplicons

Journal of Clinical Microbiology

Volumn 42, Issue 9, 2004, Pages 4223-4229

  Liu, Zhi ^a,b   Netski, Dale M ^a   Mao, Qing ^a,b   Laeyendecker, Oliver ^a   Ticehurst, John R ^a   Wang, Xiao Hong ^a,b   Thomas, David L ^a   Ray, Stuart C ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HEPATITIS C ANTIBODY; HETERODUPLEX; NUCLEOTIDE; VIRUS RNA;

ACCURACY; AMPLICON; ARTICLE; CONCENTRATION RESPONSE; ENZYME IMMUNOASSAY; GENE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; VIRUS GENOME;

AMINO ACID SEQUENCE; BASE SEQUENCE; DNA PRIMERS; GENE AMPLIFICATION; HEPACIVIRUS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; VARIATION (GENETICS);

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 4644279066     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.9.4223-4229.2004     Document Type: Article

References (35)

1. Alter, H. J., R. H. Purcell, P. V. Holland, and H. Popper. 1978. Transmissible agent in non-A, non-B hepatitis. Lancet i:459-463.
2. Alter, M. J., D. Kruszon-Moran, O. V. Nainan, G. M. McQuillan, F. Gao, L. A. Moyer, R. A. Kaslow, and H. S. Margolis. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341:556-562.
3. Alter, M. J., H. S. Margolis, K. Krawczynski, F. N. Judson, A. Mares, W. J. Alexander, P. Y. Hu, J. K. Miller, M. A. Gerber, R. E. Sampliner, E. Meeks, and M. J. Beach. 1992. The natural history of community acquired hepatitis C in the United States. N. Engl. J. Med. 327:1899-1905.
4. Boulestin, A., K. Sandres-Saune, J. L. Payen, L. Alric, M. Dubois, C. Pasquier, J. P. Vinel, J. P. Pascal, J. Puel, and J. Izopet. 2002. Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha. J. Med. Virol. 68:221-228.
5. Bracho, M. A., A. Moya, and E. Barrio. 1998. Contribution of Taq polymerase-induced errors to the estimation of RNA virus diversity. J. Gen. Virol. 79:2921-2928.
6. Clark, A. G., and T. S. Whittam. 1992. Sequencing errors and molecular evolutionary analysis. Mol. Biol. Evol. 9:744-752.
7. Curran, R., C. L. Jameson, J. K. Craggs, A. M. Grabowska, B. J. Thomson, A. Robins, W. L. Irving, and J. K. Ball. 2002. Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity. J. Gen. Virol. 83:11-23.
8. Fang, G., B. Weiser, A. Visosky, T. Moran, and H. Burger. 1999. PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA. Nat. Med. 5:239-242.
9. Farci, P., A. Shimoda, A. Coiana, G. Diaz, G. Peddis, J. C. Melpolder, A. Strazzera, D. Y. Chien, S. J. Munoz, A. Balestrieri, R. H. Purcell, and H. J. Alter. 2000. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288:339-344.
10. Farci, P., A. Shimoda, D. Wong, T. Cabezon, D. De Gioannis, A. Strazzera, Y. Shimizu, M. Shapiro, H. J. Alter, and R. H. Purcell. 1996. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc. Natl. Acad. Sci. USA 93:15394-15399.
11. Fuller, C. M., D. Vlahov, D. C. Ompad, N. Shah, A. Arria, and S. A. Strathdee. 2002. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 66:189-198.
12. Honda, M., S. Kaneko, A. Sakai, M. Unoura, S. Murakami, and K. Kobayashi. 1994. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 20:1144-1151.
13. Honda, M., R. Rijnbrand, G. Abell, D. Kim, and S. M. Lemon. 1999. Natural variation in translational activities of the 5′ nontranslated RNAs of hepatitis C virus genotypes 1a and 1b: evidence for a long-range RNA-RNA interaction outside of the internal ribosomal entry site. J. Virol. 73:4941-4951.
14. Hu, Y., L. R. Tanzer, J, Cao, C. D. Geringer, and R. E. Moore. 1998. Use of long RT-PCR to characterize splice variant mRNAs. BioTechniques. 25:224-229.
15. Jeanmougin, F., J. D. Thompson, M. Gouy, D. G. Higgins, and T. J. Gibson. 1998. Multiple sequence alignment with Clustal X. Trends Biochem. Sci. 23:403-405.
16. Kato, N., Y. Ootsuyama, T. Tanaka, M. Nakagawa, T. Nakazawa, K. Muraiso, S. Ohkoshi, M. Hijikata, and K. Shimotohno. 1992. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res. 22:107-123.
17. Kittlesen, D. J., K. A. Chianese-Bullock, Z. Q. Yao, T. J. Braciale, and Y. S. Hahn. 2000. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106:1239-1249.
18. Kolykhalov, A. A., E. V. Agapov, K. J. Blight, K. Mihalik, S. M. Feinstone, and C. M. Rice. 1997. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277:570-574.
19. Liu, S. L., A. G. Rodrigo, R. Shankarappa, G. H. Learn, L. Hsu, O. Davidov, L. P. Zhao, and J. I. Mullins. 1996. HIV quasispecies and resampling. Science 273:415-416.
20. Mangoni, E. D., D. M. Forton, G. Ruggiero, and P. Karayiannis. 2003. Hepatitis C virus E2 and NS5A region variability during sequential treatment with two interferon-alpha preparations. J. Med. Virol. 70:62-73.
21. Mao, Q., O. Laeyendecker, D. Thomas, and S. Ray. 2000. Enhanced detection of HCV quasispecies complexity during acute seroconversion through amplification and cloning of a 5.2 kb amplicon. Antivir. her. 5(suppl. 1):C118.
22. Mao, Q., S. C. Ray, O. Laeyendecker, J. R. Ticehurst, S. A. Strathdee, D. Vlahov, and D. L. Thomas. 2001. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. J. Virol. 75:3259-3267.
23. Martell, M., J. I. Esteban, J. Quer, J. Genesca, A. Weiner, R. Esteban, Guardia, and J. Gomez. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66:3225-3229.
24. Meyerhans, A., J. P. Vartanian, and S. Wain-Hobson. 1990. DNA recombination during PCR. Nucleic Acids Res. 18:1687-1691.
25. Ray, S. C., Q. Mao, R. E. Lanford, S. Bassett, O. Laeyendecker, Y. M. Wang, and D. L. Thomas. 2000. Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J. Virol. 74:3058-3066.
26. Ray, S. C., Y. M. Wang, O. Laeyendecker, J. Ticehurst, S. A. Villano, and D. L. Thomas. 1998. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as decoy. J. Virol. 73:2938-2946.
27. Rispeter, K., M. Lu, S. Lechner, A. Zibert, and M. Roggendorf. 1997. Cloning and characterization of a complete open reading frame of the hepatitis C virus genome in only two cDNA fragments. J. Gen. Virol. 78:2751-2759.
28. Rosen, H. R., G. Marousek, and S. Chou. 2002. A longitudinal analysis of T-cell epitope-coding regions of hepatitis C virus after liver transplantation. Transplantation. 74:209-216.
29. Smith, D. B., J. McAllister, C. Casino, and P. Simmonds. 1997. Virus 'quasispecies': Making a mountain out of a molehill? J. Gen. Virol. 78:1511-1519.
30. Smith, D. B., and P. Simmonds. 1997. Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J. Mol. Evol. 45:238-246.
31. Soler, M., M. Pellerin, C. E. Malnou, D. Dhumeaux, K. M. Kean, and J. M. Pawlotsky. 2002. Quasispecies heterogeneity and constraints on the evolution of the 5′ noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy. Virology 298:160-173.
32. Spiess, A. N., and R. Ivell. 2002. A highly efficient method for long-chain cDNA synthesis using trehalose and betaine. Anal. Biochem. 301:168-174.
33. Sulkowski, M. S., S. C. Ray, and D. L. Thomas. 2002. Needlestick transmission of hepatitis C. JAMA 287:2406-2413.
34. Tong, M. J., N. S. El-Farra, A. R. Reikes, and R. L. Co. 1995. Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 332:1463-1466.
35. Wang, Y. M., S. C. Ray, O. Laeyendecker, J. R. Ticehurst, and D. L. Thomas. 1998. Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single- and double-stranded DNAs. J. Clin. Microbiol. 36:2982-2989.